---
figid: PMC3720640__onc9991113440003
figtitle: 'Anti-Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous
  Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance'
organisms:
- NA
pmcid: PMC3720640
filename: onc9991113440003.jpg
figlink: /pmc/articles/PMC3720640/figure/F3/
number: F3
caption: 'Possible mechanisms of resistance to EGFR-targeted therapy in HNSCC described
  in this review: (1) overexpression of ligands, (2) activating mutations in EGFR,
  (3) translocation of EGFR to the nucleus, (4) loss of PTPRS, (5) activating Ras
  mutations, (6) downregulation of DUSP, (7) activating mutations in PIK3CA or inactivating
  mutations in PTEN, (8) activation of Src kinases, (9) dysregulation of the STAT
  pathway, (10) heterodimerization with other ErbB family members, (11) parallel signaling
  of other receptors, IGF-1R or MET, (12) overexpression of the Aurora kinase A and
  B, (13) deregulation of cyclin D1 or the A870G polymorphism, (14) loss of functional
  p53, and (15) activation of HIF-1 signaling.Abbreviations: EGFR, epidermal growth
  factor receptor; HNSCC, head and neck squamous cell carcinoma; STAT, signal transducer
  and activator of transcription.'
papertitle: 'Anti-Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous
  Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance.'
reftext: Carolien Boeckx, et al. Oncologist. 2013 Jul;18(7):850-864.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9649448
figid_alias: PMC3720640__F3
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC3720640__F3
ndex: ea67fb0b-ded3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3720640__onc9991113440003.html
  '@type': Dataset
  description: 'Possible mechanisms of resistance to EGFR-targeted therapy in HNSCC
    described in this review: (1) overexpression of ligands, (2) activating mutations
    in EGFR, (3) translocation of EGFR to the nucleus, (4) loss of PTPRS, (5) activating
    Ras mutations, (6) downregulation of DUSP, (7) activating mutations in PIK3CA
    or inactivating mutations in PTEN, (8) activation of Src kinases, (9) dysregulation
    of the STAT pathway, (10) heterodimerization with other ErbB family members, (11)
    parallel signaling of other receptors, IGF-1R or MET, (12) overexpression of the
    Aurora kinase A and B, (13) deregulation of cyclin D1 or the A870G polymorphism,
    (14) loss of functional p53, and (15) activation of HIF-1 signaling.Abbreviations:
    EGFR, epidermal growth factor receptor; HNSCC, head and neck squamous cell carcinoma;
    STAT, signal transducer and activator of transcription.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTPRS
  - SRC
  - FGR
  - FYN
  - YES1
  - KRAS
  - HRAS
  - NRAS
  - PTEN
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - DUSP5
  - DUSP1
  - DUSP2
  - DUSP3
  - DUSP4
  - DUSP6
  - EPHB2
  - MAPK1
  - MAPK3
  - TP53
  - TP63
  - TP73
  - SETD2
  - CCND1
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Src42A
  - Csk
  - Src64B
  - ras
  - Ras64B
  - Ras85D
  - Pten
  - Raf
  - Stat92E
  - Dsor1
  - Mtk
  - usp
  - Erk7
  - rl
  - p53
  - betaTub60D
  - hth
  - tgo
  - sima
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
